OMNY Health (OMNY Inc.) is pleased to announce it has partnered with the nation’s leading community-based dermatology practices to create a first-of-a-kind integrated, normalized, de-identified electronic health record (EHR) data repository for dermatological research
Jessica Walling
Practical Applications of FDA’s Guidelines on Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products
OMNY Health (OMNY Inc.) is pleased to announce it has partnered with the nation’s leading community-based dermatology practices to create a first-of-a-kind integrated, normalized, de-identified electronic health record (EHR) data repository for dermatological research
OMNY Health and Datavant Announce Alliance to Accelerate Delivery of Real-World Data Between Healthcare Stakeholders to Enhance Clinical Research and Drug Development
OMNY Health (OMNY Inc.) is pleased to announce it has partnered with the nation’s leading community-based dermatology practices to create a first-of-a-kind integrated, normalized, de-identified electronic health record (EHR) data repository for dermatological research
OMNY Health Presenting and Exhibiting at ISPOR Annual
OMNY Health (OMNY Inc.) is pleased to announce it has partnered with the nation’s leading community-based dermatology practices to create a first-of-a-kind integrated, normalized, de-identified electronic health record (EHR) data repository for dermatological research
Sensyne Health and OMNY Health Sign Teaming Agreement to Support Breakthrough Research Through the Power of Real World Data and AI
Sensyne Health plc (LSE: SENS) (“Sensyne”), the ethical Clinical AI company, and OMNY Health (“OMNY”), a leading US-based real world data company, today announced a strategic teaming relationship.
Register to View Mid-Urethral Slings for Stress Urinary Incontinence: Effectiveness and Adverse Events Using Real-World Data – OMNY Health Poster
On June 27 - July 1, 2021, this poster was on display at the virtual DIA Annual. What is the Objective of this Poster? Compare effectiveness and safety outcomes of MMUS versus FMUS in the treatment of SUI in the real-world setting Register to view this poster now!
Register to View COVID-19 Treatment Patterns in Real-World Hospital Setting – OMNY Health Poster
On June 27 - July 1, 2021, this poster was on display at the virtual DIA Annual. What is the Objective of this Poster? Characterize treatment patterns of patients hospitalized with COVID-19 in the real-world setting Register to view this poster now!
OMNY Health Launches Massive Integrated Dermatology Data Repository and Research Network to Advance Life-Changing Innovations for Patients Suffering from Skin-Related Conditions
OMNY Health (OMNY Inc.) is pleased to announce it has partnered with the nation’s leading community-based dermatology practices to create a first-of-a-kind integrated, normalized, de-identified electronic health record (EHR) data repository for dermatological research
Register to View Identifying Negative Pressure Wound Therapy for Pressure Ulcer: Effect on Outcomes and Utilization Using Real-World Data – OMNY Health Poster
On May 17-20, 2021, this poster was on display at the virtual ISPOR Annual. What is the Objective of this Poster? Evaluate the effect of negative pressure wound therapy (NPWT) on length of stay (LOS), charges, and mortality for pressure ulcer (PU) patients using...
Register to View Identifying COVID-19 Patients from Unstructured Notes: Performance of a Commercial Clinical Named Entity Recognition System – OMNY Health Poster
On May 17-20, 2021, this poster was on display at the virtual ISPOR Annual. What is the Objective of this Poster? Measure the performance of ACM-ICD-10 in detecting the presence of COVID-19 infection and related clinical concepts in a clinical document sample obtained...